XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity Investments (Tables)
6 Months Ended
Jan. 31, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Equity Investments

Equity investments consist of the following:

 

           
  

January 31,

2024

  

July 31,

2023

 
   (in thousands) 
Zedge, Inc. Class B common stock, 42,282 shares at January 31, 2024 and July 31, 2023  $138   $89 
Rafael Holdings, Inc. Class B common stock, 278,810 shares at January 31, 2024 and July 31, 2023   505    558 
Other marketable equity securities   188    1,497 
Fixed income mutual funds   4,245    4,054 
           
Current equity investments  $5,076   $6,198 
           
Visa Inc. Series C Convertible Participating Preferred Stock (“Visa Series C Preferred”)  $1,450   $1,263 
Convertible preferred stock—equity method investment   1,932    2,784 
Hedge funds   2,951    3,002 
Other   1,225    2,825 
           
Noncurrent equity investments  $7,558   $9,874 
Schedule of Carrying Value of Equity Investments

The changes in the carrying value of the Company’s equity investments without readily determinable fair values for which the Company elected the measurement alternative was as follows:

 

   2024   2023   2024   2023 
  

Three Months Ended

January 31,

  

Six Months Ended

January 31,

 
   2024   2023   2024   2023 
   (in thousands) 
Balance, beginning of period  $1,747   $1,474   $1,632   $1,501 
Adjustment for observable transactions involving a similar investment from the same issuer   202    120    187    93 
Upward adjustment           130     
Redemption   (230)       (230)    
Impairments                
                     
Balance, end of the period  $1,719   $1,594   $1,719   $1,594 
Schedule of Unrealized Gains (losses) Gains for All Equity Investments

Unrealized gains (losses) for all equity investments measured at fair value included the following:

 

   2024   2023   2024   2023 
  

Three Months Ended

January 31,

  

Six Months Ended

January 31,

 
   2024   2023   2024   2023 
   (in thousands) 
Net gains (losses) recognized during the period on equity investments  $

715

   $(228)  $(202)  $(2,169)
Less: net gains recognized during the period on equity investments sold during the period       22    130    18 
                     
Unrealized gains (losses) recognized during the period on equity investments still held at the reporting date  $715   $(250)  $(332)  $(2,187)

 

The unrealized gains and losses for all equity investments measured at fair value in the table above included the following:

 

   2024   2023   2024   2023 
  

Three Months Ended

January 31,

  

Six Months Ended

January 31,

 
   2024   2023   2024   2023 
   (in thousands) 
Unrealized gains (losses) recognized during the period on equity investments:                    
Rafael Class B common stock  $9   $82   $(53)  $9 
                     
Zedge Class B common stock  $57   $3   $49   $(24)
Summary of Changes in Equity Method Investments

The following table summarizes the change in the balance of the Company’s equity method investment:

 

   2024   2023   2024   2023 
  

Three Months Ended

January 31,

  

Six Months Ended

January 31,

 
   2024   2023   2024   2023 
   (in thousands) 
Balance, beginning of period  $2,444   $349   $2,784   $1,001 
Purchase of convertible preferred stock   336        1,009     
Equity in the net loss of investee   (506)   (542)   (1,176)   (1,012)
Amortization of equity method basis difference   (342)   (181)   (685)   (363)
                     
Balance, end of the period  $1,932   $(374)  $1,932   $(374)
Summary of Statements of Operations

Summarized financial information of the EMI was as follows:

 

   2024   2023   2024   2023 
  

Three Months Ended

January 31,

  

Six Months Ended

January 31,

 
   2024   2023   2024   2023 
   (in thousands) 
     
Revenues  $5,087   $1,818   $7,821   $3,691 
Costs and expenses:                    
Direct cost of revenues   4,085    1,535    6,482    3,228 
Selling, general and administrative   2,385    1,772    4,570    3,408 
                     
Total costs and expenses   6,470    3,307    11,052    6,636 
                     
Loss from operations   (1,383)   (1,489)   (3,231)   (2,945)
Other expense, net   

    (498)   

    (842)
                     
Net loss  $(1,383)  $(1,987)  $(3,231)  $(3,787)